These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 16528256

  • 1. Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.
    Ma J, Weisberg A, Griffin JP, Vaughan DE, Fogo AB, Brown NJ.
    Kidney Int; 2006 Mar; 69(6):1064-72. PubMed ID: 16528256
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD, Albornoz F, Griffin JP, Crandall DL, Elokdah H, Fogo AB, Vaughan DE, Brown NJ.
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [Abstract] [Full Text] [Related]

  • 3. Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney.
    Irita J, Okura T, Jotoku M, Nagao T, Enomoto D, Kurata M, Desilva VR, Miyoshi K, Matsui Y, Uede T, Denhardt DT, Rittiling SR, Higaki J.
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F833-44. PubMed ID: 21734100
    [Abstract] [Full Text] [Related]

  • 4. Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells.
    Schreier B, Rabe S, Schneider B, Ruhs S, Grossmann C, Hauptmann S, Blessing M, Neumann J, Gekle M.
    Hypertens Res; 2011 May; 34(5):623-9. PubMed ID: 21346767
    [Abstract] [Full Text] [Related]

  • 5. Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage.
    Knier B, Cordasic N, Klanke B, Heusinger-Ribeiro J, Daniel C, Veelken R, Hartner A, Hilgers KF.
    J Hypertens; 2011 Aug; 29(8):1602-12. PubMed ID: 21610512
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
    Krag S, Danielsen CC, Carmeliet P, Nyengaard J, Wogensen L.
    Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
    [Abstract] [Full Text] [Related]

  • 7. Critical role of apoptosis signal-regulating kinase 1 in aldosterone/salt-induced cardiac inflammation and fibrosis.
    Nakamura T, Kataoka K, Fukuda M, Nako H, Tokutomi Y, Dong YF, Ichijo H, Ogawa H, Kim-Mitsuyama S.
    Hypertension; 2009 Sep; 54(3):544-51. PubMed ID: 19581502
    [Abstract] [Full Text] [Related]

  • 8. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.
    Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, Freeman M, Vaughan DE, Fogo AB.
    Kidney Int; 2000 Sep; 58(3):1219-27. PubMed ID: 10972684
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition.
    Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, Vaughan DE.
    Circulation; 2001 Aug 14; 104(7):839-44. PubMed ID: 11502712
    [Abstract] [Full Text] [Related]

  • 10. Aldosterone and not plasminogen activator inhibitor-1 is a critical mediator of early angiotensin II/NG-nitro-L-arginine methyl ester-induced myocardial injury.
    Oestreicher EM, Martinez-Vasquez D, Stone JR, Jonasson L, Roubsanthisuk W, Mukasa K, Adler GK.
    Circulation; 2003 Nov 18; 108(20):2517-23. PubMed ID: 14581407
    [Abstract] [Full Text] [Related]

  • 11. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure.
    Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ.
    Hypertension; 2009 Sep 18; 54(3):537-43. PubMed ID: 19635989
    [Abstract] [Full Text] [Related]

  • 12. Endogenous aldosterone contributes to acute angiotensin II-stimulated plasminogen activator inhibitor-1 and preproendothelin-1 expression in heart but not aorta.
    Luther JM, Wang Z, Ma J, Makhanova N, Kim HS, Brown NJ.
    Endocrinology; 2009 May 18; 150(5):2229-36. PubMed ID: 19106220
    [Abstract] [Full Text] [Related]

  • 13. Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.
    Rossini M, Naito T, Yang H, Freeman M, Donnert E, Ma LJ, Dunn SR, Sharma K, Fogo AB.
    Nephrol Dial Transplant; 2010 Jun 18; 25(6):1803-10. PubMed ID: 20061322
    [Abstract] [Full Text] [Related]

  • 14. Tranilast attenuates myocardial fibrosis in association with suppression of monocyte/macrophage infiltration in DOCA/salt hypertensive rats.
    Kagitani S, Ueno H, Hirade S, Takahashi T, Takata M, Inoue H.
    J Hypertens; 2004 May 18; 22(5):1007-15. PubMed ID: 15097242
    [Abstract] [Full Text] [Related]

  • 15. Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury.
    Abderrahmani R, François A, Buard V, Benderitter M, Sabourin JC, Crandall DL, Milliat F.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):942-8. PubMed ID: 19480973
    [Abstract] [Full Text] [Related]

  • 16. TGF-beta type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis.
    Song CY, Kim BC, Hong HK, Lee HS.
    Kidney Int; 2007 May 01; 71(9):882-8. PubMed ID: 17299519
    [Abstract] [Full Text] [Related]

  • 17. Aldosterone-and-salt-induced cardiac fibrosis is independent from angiotensin II type 1a receptor signaling in mice.
    Kagiyama S, Matsumura K, Fukuhara M, Sakagami K, Fujii K, Iida M.
    Hypertens Res; 2007 Oct 01; 30(10):979-89. PubMed ID: 18049031
    [Abstract] [Full Text] [Related]

  • 18. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition.
    Kaikita K, Schoenhard JA, Painter CA, Ripley RT, Brown NJ, Fogo AB, Vaughan DE.
    J Mol Cell Cardiol; 2002 Jun 01; 34(6):617-27. PubMed ID: 12054849
    [Abstract] [Full Text] [Related]

  • 19. Excess aldosterone under normal salt diet induces cardiac hypertrophy and infiltration via oxidative stress.
    Yoshida K, Kim-Mitsuyama S, Wake R, Izumiya Y, Izumi Y, Yukimura T, Ueda M, Yoshiyama M, Iwao H.
    Hypertens Res; 2005 May 01; 28(5):447-55. PubMed ID: 16156509
    [Abstract] [Full Text] [Related]

  • 20. [Effect of aldosterone on the expression of plasminogen activator inhibitor-1 in renal mesangial cells: experiment with rat renal mesangial cells].
    Yuan J, Jia RH, Bao Y.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 11; 87(34):2439-42. PubMed ID: 18036328
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.